C WorldWide Group Holding A/S - EAGLE PHARMACEUTICALS INC ownership

EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 120 filers reported holding EAGLE PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.42 and the average weighting 1.0%.

Quarter-by-quarter ownership
C WorldWide Group Holding A/S ownership history of EAGLE PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$1,255,000
-56.4%
18,102
-52.5%
0.02%
-60.0%
Q2 2018$2,880,000
+76.7%
38,070
+23.1%
0.04%
+60.0%
Q1 2018$1,630,000
-16.0%
30,929
-14.9%
0.02%
-10.7%
Q4 2017$1,941,000
-49.2%
36,327
-43.3%
0.03%
-48.1%
Q3 2017$3,819,000
-0.7%
64,042
+31.4%
0.05%
-6.9%
Q2 2017$3,845,000
-28.8%
48,741
-25.1%
0.06%
-36.3%
Q1 2017$5,398,000
+26.9%
65,085
+21.4%
0.09%
+11.0%
Q4 2016$4,253,000
-27.1%
53,600
-35.7%
0.08%
-20.4%
Q3 2016$5,838,000
+54.5%
83,407
-14.4%
0.10%
+43.1%
Q2 2016$3,778,000
-53.1%
97,407
-51.0%
0.07%
-53.8%
Q1 2016$8,056,000
-58.5%
198,907
-9.1%
0.16%
-54.1%
Q4 2015$19,410,000
-4.3%
218,907
-20.1%
0.34%
-0.3%
Q3 2015$20,277,000
-55.1%
273,907
-51.0%
0.34%
+5.6%
Q2 2015$45,186,000
+702.6%
558,814
+315.8%
0.32%
+303.8%
Q1 2015$5,630,000
+284.8%
134,407
+42.4%
0.08%
+263.6%
Q4 2014$1,463,000
-14.7%
94,407
-32.6%
0.02%
-12.0%
Q3 2014$1,715,000140,0000.02%
Other shareholders
EAGLE PHARMACEUTICALS INC shareholders Q2 2016
NameSharesValueWeighting ↓
Park West Asset Management LLC 1,120,235$53,749,0002.66%
TANG CAPITAL MANAGEMENT LLC 255,616$12,264,0001.19%
Smith, Graham & Co., Investment Advisors, LP 158,671$7,613,0000.92%
ARMISTICE CAPITAL, LLC 282,000$13,530,0000.59%
Capital Impact Advisors, LLC 35,815$1,718,0000.57%
Matarin Capital Management, LLC 58,977$2,830,0000.56%
GLOBEFLEX CAPITAL L P 31,702$1,521,0000.39%
CHARTWELL INVESTMENT PARTNERS, LLC 200,246$9,608,0000.37%
Stanley-Laman Group, Ltd. 24,000$1,152,0000.28%
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. 264$13,0000.20%
View complete list of EAGLE PHARMACEUTICALS INC shareholders